Cheng-Yuan Peng Selected Research

Cheng-Yuan Peng Research Topics

Disease

54	Chronic Hepatitis B 03/2024 - 01/2009
51	Fibrosis (Cirrhosis) 04/2024 - 02/2006
49	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 03/2002
47	Chronic Hepatitis C 04/2024 - 07/2007
41	Infections 05/2024 - 07/2007
15	Neoplasms (Cancer) 04/2024 - 03/2002
12	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 08/2012
11	Hepatitis C 03/2024 - 03/2014
11	Virus Diseases (Viral Diseases) 04/2023 - 01/2006
9	Hepatitis B 11/2023 - 01/2006
7	Diabetes Mellitus 04/2024 - 01/2020
7	Liver Diseases (Liver Disease) 04/2024 - 07/2012
6	Liver Neoplasms (Liver Cancer) 04/2024 - 12/2016
5	Hemorrhage 07/2020 - 02/2006
4	Chronic Renal Insufficiency 02/2022 - 07/2020
4	Disease Progression 01/2022 - 01/2011
3	Reinfection 08/2022 - 01/2022
3	Inflammation (Inflammations) 06/2017 - 02/2009
2	Hyperlipidemias (Hyperlipidemia) 04/2024 - 01/2023
2	Type 2 Diabetes Mellitus (MODY) 04/2024 - 01/2024
2	Non-alcoholic Fatty Liver Disease 01/2024 - 01/2022
2	Fatty Liver 01/2024 - 12/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 10/2023
2	Obesity 10/2023 - 01/2023
2	Jaundice (Icterus) 12/2021 - 12/2008
2	Viremia 12/2021 - 03/2013
2	Ascites 12/2021 - 01/2019
2	Necrosis 11/2021 - 01/2003
2	Chronic Kidney Failure (Chronic Renal Failure) 08/2021 - 01/2021
2	Medically Unexplained Symptoms 01/2019 - 06/2017
2	Major Depressive Disorder (Major Depressive Disorders) 01/2019 - 01/2016
2	Cholecystitis 01/2019 - 06/2013
2	Cytopenia 05/2016 - 05/2009
1	Communicable Diseases (Infectious Diseases) 01/2024

Drug/Important Bio-Agent (IBA)

54	Antiviral Agents (Antivirals)IBA 05/2024 - 06/2008
32	entecavir FDA Link 01/2024 - 01/2009
30	InterferonsIBA 01/2022 - 07/2007
25	Ribavirin (Virazole)FDA LinkGeneric 01/2022 - 06/2008
19	Hepatitis B e AntigensIBA 03/2024 - 01/2009
15	Tenofovir (Viread)FDA Link 01/2024 - 08/2012
11	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2023 - 02/2015
10	SofosbuvirIBA 01/2024 - 01/2016
9	BilirubinIBA 04/2023 - 05/2016
8	daclatasvirIBA 01/2021 - 11/2014
8	Interferon-alpha (Interferon Alfa)IBA 02/2020 - 02/2009
7	asunaprevirIBA 01/2021 - 11/2014
6	Biomarkers (Surrogate Marker)IBA 02/2024 - 07/2018
6	velpatasvirIBA 01/2024 - 12/2018
6	AlbuminsIBA 01/2023 - 01/2020
6	Fetal Proteins (Fetoprotein)IBA 01/2023 - 01/2017
5	glecaprevir and pibrentasvirIBA 04/2024 - 12/2018
5	Alanine Transaminase (SGPT)IBA 04/2024 - 11/2011
5	Sorafenib (BAY 43-9006)FDA Link 11/2023 - 04/2016
5	grazoprevirIBA 07/2023 - 11/2016
5	elbasvirIBA 07/2023 - 11/2016
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2009
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2023 - 01/2020
4	sofosbuvir drug combination ledipasvirIBA 08/2022 - 07/2016
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 01/2017
3	Hemoglobins (Hemoglobin)IBA 01/2024 - 03/2015
3	Opioid Analgesics (Opioids)IBA 07/2023 - 11/2016
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2020
3	NucleotidesIBA 06/2021 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2006
3	peginterferon alfa-2a (Pegasys)FDA Link 01/2019 - 01/2015
3	adefovirIBA 07/2018 - 01/2009
3	Telbivudine FDA Link 03/2016 - 01/2014
2	Metformin (Glucophage)FDA LinkGeneric 04/2024 - 01/2023
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024 - 01/2023
2	Immunoglobulins (Immunoglobulin)IBA 01/2024 - 02/2015
2	tenofovir alafenamideIBA 10/2023 - 06/2018
2	Carrier Proteins (Binding Protein)IBA 10/2022 - 04/2020
2	Transaminases (Aminotransferases)IBA 12/2021 - 05/2009
2	NivolumabIBA 11/2021 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2020 - 05/2009
2	Ritonavir (Norvir)FDA Link 12/2018 - 08/2018
2	Arachidonic Acid (Vitamin F)IBA 06/2017 - 03/2010
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2017 - 03/2010
2	CytokinesIBA 06/2017 - 02/2009
2	Eicosapentaenoic AcidIBA 06/2017 - 03/2010
2	TabletsIBA 01/2017 - 07/2016
2	CollagenIBA 08/2016 - 01/2015
2	NucleosidesIBA 06/2016 - 01/2009
2	phosphomannopentaose sulfateIBA 08/2014 - 05/2009
2	Indicators and Reagents (Reagents)IBA 01/2014 - 08/2012
2	Lamivudine (Epivir)FDA Link 01/2014 - 12/2010
1	A-factor (Streptomyces)IBA 01/2024
1	LipidsIBA 10/2023

Therapy/Procedure

80	Therapeutics 04/2024 - 07/2007
4	Aftercare (After-Treatment) 08/2022 - 07/2016
3	Drug Therapy (Chemotherapy) 01/2020 - 01/2011
3	Liver Transplantation 01/2019 - 12/2008
3	Radiofrequency Ablation 01/2018 - 05/2002
2	Organ Transplantation 07/2020 - 01/2019
2	Duration of Therapy 06/2020 - 01/2017
2	Surgical Instruments (Clip) 01/2020 - 12/2016
2	Radiotherapy 01/2018 - 12/2016
2	Cholecystectomy 06/2013 - 02/2007
2	Plasma Exchange 10/2011 - 12/2008
2	Ligation 05/2010 - 02/2006